SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-31
👔
ACADIA PHARMACEUTICALS INC
@ACAD_InsiderForm 4 Filing: Thompson Elizabeth H.Z. Sells $432,662.54 of $ACAD
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
ACADIA PHARMACEUTICALS INC
Ticker: $ACAD
Transaction Value
$432,662.54
Price/Share: $8.86
transaction date
2026-07-30
Shares: 48,830
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Thompson Elizabeth H.Z., holds the title of EVP, Head of Research & Dev at ACADIA PHARMACEUTICALS INC.
On 2026-07-30, the insider transacted 48,830 shares.The shares were transacted at a weighted average price of $8.86 per share, resulting in a total market-relevant value of $432,662.54.
Executive Summary Summary
Thompson Elizabeth H.Z. (EVP, Head of Research & Dev) sold $433K of $ACAD
Post-Transaction Position: 19,044 shares
SEC Accession No: 0001861477-26-000005 (CIK: 1861477)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.